Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
Status:
Completed
Trial end date:
2012-11-13
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, double-blind study comparing intravesical injection of
BOTOX to placebo. Study subjects will be randomized (1:1 ratio) to one of the following
treatment groups:
Phase:
Phase 3
Details
Lead Sponsor:
Weill Medical College of Cornell University
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA